CA1087093A - Vaccines based on a ribosome fraction combined with a saccharide fraction from bacteria - Google Patents

Vaccines based on a ribosome fraction combined with a saccharide fraction from bacteria

Info

Publication number
CA1087093A
CA1087093A CA284,028A CA284028A CA1087093A CA 1087093 A CA1087093 A CA 1087093A CA 284028 A CA284028 A CA 284028A CA 1087093 A CA1087093 A CA 1087093A
Authority
CA
Canada
Prior art keywords
corynebacterium
fraction
serratia
saccharide
extracted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA284,028A
Other languages
English (en)
French (fr)
Inventor
Jacques Durand
Gerard Normier
Lucien Dussourd D'hinterland
Anne M. Pinel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre SA filed Critical Pierre Fabre SA
Application granted granted Critical
Publication of CA1087093A publication Critical patent/CA1087093A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CA284,028A 1976-08-06 1977-08-04 Vaccines based on a ribosome fraction combined with a saccharide fraction from bacteria Expired CA1087093A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7624124 1976-08-06
FR7624124A FR2360314A2 (fr) 1976-08-06 1976-08-06 Nouveaux vaccins perfectionnes a base de fractions ribosomales

Publications (1)

Publication Number Publication Date
CA1087093A true CA1087093A (en) 1980-10-07

Family

ID=9176646

Family Applications (1)

Application Number Title Priority Date Filing Date
CA284,028A Expired CA1087093A (en) 1976-08-06 1977-08-04 Vaccines based on a ribosome fraction combined with a saccharide fraction from bacteria

Country Status (9)

Country Link
JP (1) JPS5320418A (de)
AU (1) AU511331B2 (de)
BE (1) BE857014R (de)
CA (1) CA1087093A (de)
DE (1) DE2735411C2 (de)
ES (1) ES461415A2 (de)
FR (1) FR2360314A2 (de)
GB (1) GB1590144A (de)
ZA (1) ZA774733B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4346074A (en) * 1978-08-24 1982-08-24 National Research Development Corp. Pasteurellosis vaccines
JPS55106066U (de) * 1979-01-19 1980-07-24
JPS639754Y2 (de) * 1979-01-25 1988-03-23
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4388299A (en) 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
JPS58191628A (ja) * 1982-05-04 1983-11-08 Aisin Seiki Co Ltd 車輌ル−フパネル開閉装置
JPS626614A (ja) * 1985-07-03 1987-01-13 株式会社チノー 温室の天窓制御装置
JPS62104526A (ja) * 1985-10-30 1987-05-15 株式会社チノー 温室の制御装置
FR2596064B1 (fr) * 1986-03-18 1990-02-02 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen
GB2370839A (en) * 2001-01-06 2002-07-10 Benedikt Timmerman Immunogenic complex useful for disease control

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51142528A (en) * 1975-05-19 1976-12-08 Fabre Sa Pierre Production of vaccine based on antigenic libosome fractionation

Also Published As

Publication number Publication date
BE857014R (fr) 1978-01-20
DE2735411C2 (de) 1982-07-29
ZA774733B (en) 1978-07-26
ES461415A2 (es) 1978-07-16
FR2360314A2 (fr) 1978-03-03
AU511331B2 (en) 1980-08-14
DE2735411A1 (de) 1978-02-09
AU2753877A (en) 1979-02-08
JPS5320418A (en) 1978-02-24
GB1590144A (en) 1981-05-28
FR2360314B2 (de) 1980-04-25

Similar Documents

Publication Publication Date Title
CA1087093A (en) Vaccines based on a ribosome fraction combined with a saccharide fraction from bacteria
US4460575A (en) Vaccinal complex containing a specific antigen and vaccine containing it
Wicken et al. Bacterial cell surface amphiphiles
Westphal Bacterial endotoxins (part 1 of 2)
CA1243954A (en) Immunogenic protein or peptide complex, method of producing said complex and the use thereof as an immune stimulant and as a vaccine
Mackie et al. Morphological stabilization of capsules of group B streptococci, types Ia, Ib, II, and III, with specific antibody
US11124815B2 (en) Immunotherapeutic potential of modified lipooligosaccharides/lipid A
Rietschel et al. Pyrogenicity and immunogenicity of lipid A complexed with bovine serum albumin or human serum albumin
US20110250224A1 (en) Adjuvant combinations of liposomes and mycobacterial lipids for immunization compositions and vaccines
Taylor et al. Chemical and biological properties of an extracellular lipopolysaccharide from Escherichia coli grown under lysine-limiting conditions
JPH0662434B2 (ja) グラム陰性菌による感染に対する接合ワクチン及びその使用法
Yamamoto et al. The use of lipoteichoic acid (LTA) from Streptococcus pyogenes to induce a serum factor causing tumour necrosis.
US4606919A (en) Vaccine for the treatment of urinary tract infections containing aluminum phosphate
US20070031447A1 (en) Method of isolating biologically active fraction containing clinically acceptable native S-lipopolysaccharides obtained from bacteria producing endotoxic lipopolysaccharides
JPH05500056A (ja) アジュバント複合体
Reynolds Pulmonary host defenses in rabbits after immunization with Pseudomonas antigens: the interaction of bacteria, antibodies, macrophages, and lymphocytes
US10232026B2 (en) Vaccine for mycoplasma infection
Berger et al. Increased host resistance to infection elicited by lipopolysaccharides from Brucella abortus
Westphal et al. V. Bacterial endotoxins
Behling et al. Immunostimulation by LPS and its derivatives
NL192326C (nl) Werkwijze voor het bereiden van een geneesmiddel, waarbij een gezuiverd, ontgift endotoxine samen met een drager en eventueel andere toevoegingen in een voor therapeutische toediening geschikte vorm wordt gebracht.
RU2083223C1 (ru) Способ получения поликомпонентной вакцины для иммунотерапии заболеваний, вызываемых условно-патогенными микроорганизмами
IE46618B1 (en) Peptide complexes of desoxyribonucleic acid(dna)obtained from dna-containing organisms
Tadayon et al. The capacity of various fractions of Pasteurella haemolytica to stimulate protective immunity in mice and hamsters
Raichvarg et al. Chemical composition and biological activities of a phenol-water extract from Haemophilus influenzae type a

Legal Events

Date Code Title Description
MKEX Expiry